Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Minako, Akiyama"'
Autor:
Yukiko Komeno, Minako Akiyama, Yasumi Okochi, Hitoshi Tokuda, Keiko Abe, Kuniko Iihara, Tomiko Ryu
Publikováno v:
Case Reports in Hematology, Vol 2019 (2019)
A 59-year-old man was treated for rheumatoid arthritis (RA) for 12 years with methotrexate (MTX) and prednisolone. After MTX-associated interstitial pneumonia developed, he was treated with cyclophosphamide and prednisolone for 7 months. Arthritis wo
Externí odkaz:
https://doaj.org/article/e02c84fa71fc4a398b84358039b8794b
Autor:
Mariko Gunji, Chika Sawa, Minako Akiyama, Shumpei Mukai, Takashi Takaki, Dedong Kang, Kazuho Honda
Publikováno v:
Medical molecular morphology.
Gemcitabine (GEM) is an anticancer drug inhibiting DNA synthesis. Glomerular thrombotic microangiopathy (TMA) has been reported as an adverse effect. However, the precise mechanism of GEM-induced endothelial injury remains unknown. Cultured human umb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00098060058b0b0393452491ad331399
https://pubmed.ncbi.nlm.nih.gov/36622466
https://pubmed.ncbi.nlm.nih.gov/36622466
Autor:
Nobuhiro Kanazawa, Maki Abe, Minako Akiyama, Masayuki Iyoda, Motonori Sugiyama, Yukihiro Wada, Yasuto Shikida, Takanori Shibata, Kazuho Honda
Publikováno v:
CEN Case Rep
Ustekinumab (UST), an interleukin (IL)-12/IL-23-blocking monoclonal antibody, is a novel therapeutic option for Crohn’s disease (CD). We describe a 24-year-old man with CD who showed an abrupt decline in renal function after administration of UST.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83d67cdb777b6ad72bae7692b8fac811
https://doi.org/10.1007/s13730-020-00457-x
https://doi.org/10.1007/s13730-020-00457-x
Publikováno v:
Transactions of Japan Society of Kansei Engineering. 19:335-342
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::903651c3b58c031fa7ce753cfe329452
https://doi.org/10.5057/jjske.tjske-d-19-00050
https://doi.org/10.5057/jjske.tjske-d-19-00050
Autor:
Minako Akiyama, Kosuke Shimomura, Hiroshi Yoshimoto, Minako Sako, Makoto Kodama, Keiko Abe, Mariko Gunji, Dedong Kang, Takashi Takaki, Yukihiro Wada, Masayuki Iyoda, Kazuho Honda
Publikováno v:
Virchows Archiv : an international journal of pathology. 481(4)
Intestinal immunity has been closely associated with the pathogenesis and progression of renal diseases, a relationship known as the “gut–kidney axis.” To determine the association between immunoglobulin A nephropathy (IgAN) and Crohn’s disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f7a03ffb9fddaebdaea30fdb6e1a90d
https://pubmed.ncbi.nlm.nih.gov/35809093
https://pubmed.ncbi.nlm.nih.gov/35809093
Autor:
Tomiko Ryu, Keiko Abe, Yukiko Komeno, Kuniko Iihara, Yasumi Okochi, Minako Akiyama, Hitoshi Tokuda
Publikováno v:
Case Reports in Hematology
Case Reports in Hematology, Vol 2019 (2019)
Case Reports in Hematology, Vol 2019 (2019)
A 59-year-old man was treated for rheumatoid arthritis (RA) for 12 years with methotrexate (MTX) and prednisolone. After MTX-associated interstitial pneumonia developed, he was treated with cyclophosphamide and prednisolone for 7 months. Arthritis wo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5594bb9bedede65241f59ea77cf807fe
https://doi.org/10.1155/2019/8947616
https://doi.org/10.1155/2019/8947616
Autor:
Kosuke Shimomura, Kei Noguchi, Yuta Inagawa, Hiroshi Yoshimoto, Shigeru Hosaka, Koso Egi, Koji Takeshita, Minako Akiyama
Publikováno v:
Nihon Toseki Igakkai Zasshi. 52:643-649
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::983c2a77ddc4a1963222bb5b7ccdeb56
https://doi.org/10.4009/jsdt.52.643
https://doi.org/10.4009/jsdt.52.643
Autor:
Mio Ueda, Minako Akiyama, Shinnichi Iwai, Miho Nagai, Eiichiro Kanda, Yume Nagaoka, Yoshihiko Kanno, Michio Nagaoka, Rie Suzuki, Kakei Ryu, Yoshitaka Miyaoka, Yoshiko Tanaka, Hiroshi Yoshimoto
Publikováno v:
Hemodialysis International. 22:388-393
Introduction: Topiroxostat, a recently developed xanthine oxidase inhibitor, is expected to have fewer adverse effects than allopurinol because it has different mechanism of action from alloprinol. However, its dosage, usage and safety have not been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50f3d24543183ebe2cdeb34309cc8430
https://doi.org/10.1111/hdi.12620
https://doi.org/10.1111/hdi.12620
Autor:
Yume, Nagaoka, Yoshiko, Tanaka, Hiroshi, Yoshimoto, Rie, Suzuki, Kakei, Ryu, Mio, Ueda, Minako, Akiyama, Miho, Nagai, Yoshitaka, Miyaoka, Eiichiro, Kanda, Shinnichi, Iwai, Michio, Nagaoka, Yoshihiko, Kanno
Publikováno v:
Hemodialysis international. International Symposium on Home Hemodialysis. 22(3)
Topiroxostat, a recently developed xanthine oxidase inhibitor, is expected to have fewer adverse effects than allopurinol because it has different mechanism of action from alloprinol. However, its dosage, usage and safety have not been established in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e3a130eacddfd02b2e84617c8b58ad32
https://pubmed.ncbi.nlm.nih.gov/29227568
https://pubmed.ncbi.nlm.nih.gov/29227568
Autor:
Minako Akiyama
Publikováno v:
Advances in Intelligent Systems and Computing ISBN: 9783319615776
PAAMS (Special Sessions)
PAAMS (Special Sessions)
Beauty is a factor which is really difficult to measure or evaluate objectively, since every person can have their own preferences. However, it is common for beauty patterns to tend to be similar in communities, mainly because of different cultural f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::212f5efce4c67b5d5659e97b760ccec2
https://doi.org/10.1007/978-3-319-61578-3_52
https://doi.org/10.1007/978-3-319-61578-3_52
